C. Mosci

发表

Multicenter External Validation of the Liverpool Uveal Melanoma Prognosticator Online: An OOG Collaborative Study

N. Bornfeld, A. Eleuteri, S. Viaggi, 2020, Cancers.

Treatment of uncomplicated cases of rhegmatogenous retinal detachment with an expanding gas bubble.

R. Terrile, C. Mosci, M. Trillo, 1993, Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde.

Quantitative echography in primary uveal melanoma treated by proton beam therapy.

A. Barla, S. Mosci, C. Mosci, 2014, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.

Analysis of the Expression and Single-Nucleotide Variant Frequencies of the Butyrophilin-like 2 Gene in Patients With Uveal Melanoma.

M. Pistillo, P. Queirolo, M. Mandalà, 2016, JAMA ophthalmology.

Design and commissioning of the non‐dedicated scanning proton beamline for ocular treatment at the synchrotron‐based CNAO facility

Roberto Orecchia, Guido Baroni, Mario Ciocca, 2019, Medical physics.

Proton Beam Radiotherapy of Uveal Melanoma: Italian Patients Treated in Nice, France

A. Barla, S. Squarcia, S. Mosci, 2009, European journal of ophthalmology.

Mutation frequencies of GNAQ, GNA11, BAP1, SF3B1, EIF1AX and TERT in uveal melanoma: detection of an activating mutation in the TERT gene promoter in a single case of uveal melanoma

S. Zupo, S. Viaggi, M. Gualco, 2014, British Journal of Cancer.

In uveal melanoma Gα-protein GNA11 mutations convey a shorter disease-specific survival and are more strongly associated with loss of BAP1 and chromosomal alterations than Gα-protein GNAQ mutations.

P. Monti, S. Viaggi, R. Jockers, 2022, European journal of cancer.

Visual Outcomes of Parapapillary Uveal Melanomas Following Proton Beam Therapy.

J. Thariat, J. Herault, W. Sauerwein, 2016, International Journal of Radiation Oncology, Biology, Physics.

Optimized macular recovery test for the early diagnosis and risk prediction of retinopathy in diabetics

C. Mosci, M. Zingirian, P. Capris, 1987, Acta diabetologia latina.

New concepts in the diagnosis and management of choroidal metastases

J. Thariat, L. Kodjikian, C. Mosci, 2019, Progress in Retinal and Eye Research.

HPV16 conjunctival squamous cell carcinoma.

C. Mosci, S. Chiodi, A. Castaldi, 2022, The American journal of the medical sciences.

Conjunctival melanoma copy number alterations and correlation with mutation status, tumor features, and clinical outcome

H. Heimann, B. Damato, A. Taktak, 2019, Pigment cell & melanoma research.

Potential Onco-Suppressive Role of miR122 and miR144 in Uveal Melanoma through ADAM10 and C-Met Inhibition

P. Queirolo, M. Gualco, S. Ferrini, 2020, Cancers.

Potential Role of Soluble c-Met as a New Candidate Biomarker of Metastatic Uveal Melanoma.

P. Queirolo, S. Ferrini, Ulrich Pfeffer, 2015, JAMA ophthalmology.

ADAM10 correlates with uveal melanoma metastasis and promotes in vitro invasion

P. Queirolo, M. Gualco, S. Ferrini, 2014, Pigment cell & melanoma research.

Comparison of Clinical Outcomes for Patients with Large Choroidal Melanoma after Primary Treatment with Enucleation or Proton Beam Radiotherapy

A. Barla, S. Mosci, J. Herault, 2012, Ophthalmologica.

Management of choroidal metastases.

J. Thariat, P. Marcy, J. Herault, 2014, Cancer treatment reviews.

Evidence of epidermal growth factor receptor expression in uveal melanoma: inhibition of epidermal growth factor-mediated signalling by Gefitinib and Cetuximab triggered antibody-dependent cellular cytotoxicity.

A. Poggi, A. Amaro, Ulrich Pfeffer, 2013, European journal of cancer.

PERATIVE ABSTRACTS of the XX PTCOG MEETING held in Chester , England May 16-18 1994

F., N. Bornfeld, F. Demard, 2008 .

COMPARATIVE EFFECTIVENESS OF PROTON BEAM VERSUS PHOTODYNAMIC THERAPY TO SPARE THE VISION IN CIRCUMSCRIBED CHOROIDAL HEMANGIOMA.

J. Thariat, J. Salleron, J. Herault, 2020, Retina.

Transpupillary Thermotherapy for Circumscribed Choroidal Hemangiomas: First Choice in Therapy

C. Mosci, M. Zingirian, A. Polizzi, 2001, European journal of ophthalmology.

Proton Beam Therapy for Iris Melanomas in 107 Patients.

J. Thariat, J. Salleron, J. Herault, 2017, Ophthalmology.

Mda-9/Syntenin Is Expressed in Uveal Melanoma and Correlates with Metastatic Progression

M. Cilli, P. Queirolo, M. Gualco, 2012, PloS one.

Prognostic value of chromosomal imbalances, gene mutations, and BAP1 expression in uveal melanoma

S. Viaggi, A. Amaro, D. Coviello, 2018, Genes, chromosomes & cancer.

Classification of proliferative diabetic retinopathy

C. Mosci, F. Piccolino, M. Zingirian, 2005, Graefe's Archive for Clinical and Experimental Ophthalmology.

Potential Role of Soluble c-Met as a New Candidate Biomarker of Metastatic Uveal Melanoma.

P. Queirolo, S. Ferrini, Ulrich Pfeffer, 2015, JAMA ophthalmology.

Visual Outcomes of Parapapillary Uveal Melanomas Following Proton Beam Therapy.

J. Thariat, J. Herault, W. Sauerwein, 2016, International journal of radiation oncology, biology, physics.